Can Albumin/C-reactive Protein Ratio be Utilized for Predicting Gestational Diabetes Diagnosis or the Adverse Outcomes

NACompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

February 3, 2021

Primary Completion Date

February 3, 2022

Study Completion Date

July 3, 2022

Conditions
Gestational Diabetes Mellitus in Pregnancy
Interventions
DIAGNOSTIC_TEST

Intervention/Exposure for the GDM Group (Experimental Arm)

"Gestational Diabetes Diagnosis: The intervention for this group involves the diagnostic procedure of the 100-gram oral glucose tolerance test (OGTT) after an initial glucose challenge test (GCT) with a result equal to or greater than 140 mg/dL. The test assesses fasting plasma glucose and post-glucose consumption plasma glucose levels at 1 hour and 2 hours, which is used to diagnose GDM.~Biomarker Analysis: The albumin to high-sensitivity C-reactive protein (hsCRP) ratio is measured as a biomarker to explore its potential role in GDM diagnosis and related pregnancy outcomes."

DIAGNOSTIC_TEST

Intervention/Exposure for the Control Group

"Glucose Challenge Test (GCT): The control group participants are exposed to the glucose challenge test (GCT), where plasma glucose levels are measured one hour after the consumption of 50 grams of glucose. If their glucose levels are below 140 mg/dL, they are categorized as not having GDM.~Biomarker Analysis: Similar to the GDM group, the albumin to hsCRP ratio is measured for participants in the control group to compare the biomarker levels between those with and without GDM."

Trial Locations (1)

16310

Bursa Yuksek Ihtisas Training and Research Hospital, University of Health Sciences, Bursa

All Listed Sponsors
collaborator

Bursa Yuksek Ihtisas Training and Research Hospital

OTHER_GOV

lead

ALI BAHADIRLI

OTHER

NCT06761053 - Can Albumin/C-reactive Protein Ratio be Utilized for Predicting Gestational Diabetes Diagnosis or the Adverse Outcomes | Biotech Hunter | Biotech Hunter